Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Early Monday Report - More Moves Out Of China
January 09, 2022
Tickers
ALKS
BIIB
CGEN
EXEL
Tags
Stocks / Equities
Pharma/Biotech
Financial
From
TalkMarkets
Is The Launch Of A Fund A Sell Signal For An Asset?
January 09, 2022
Tickers
BITO
BNTX
PFE
RJA
Tags
Healthcare
ETFs
Market News
From
TalkMarkets
There Is A Skip In The Song
January 09, 2022
Tickers
ARKK
IBB
KRE
QQQ
Tags
Market News
Energy
Financial
From
TalkMarkets
Week In Review: China Biopharma Books $500 Million Of Deals To Start 2022
January 08, 2022
Tickers
SPHDF
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Post-Jobs Report Friday
January 07, 2022
Tickers
ANFGF
AY
CCJ
MELI
Tags
Nonrenewable Energy
Technology
Pharma/Biotech
From
TalkMarkets
Post-Fed Thursday
January 06, 2022
Tickers
ARKK
CTRA
EXEL
GNFT
Tags
Pharma/Biotech
Stocks / Equities
Gold/Precious Metals
From
TalkMarkets
DarioHealth Announces Two New Contracts within the Employer Market
January 06, 2022
Tickers
DRIO
Tags
Market News
Pharma/Biotech
From
TalkMarkets
Omicron In The Asia Pipeline
January 05, 2022
Tickers
MRNA
PFE
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Market Briefing For Wednesday, Jan. 5
January 05, 2022
Tickers
AEHR
BNO
F
FCAU
Tags
Technology
Bonds
Pharma/Biotech
From
TalkMarkets
Market Briefing For Tuesday, Jan. 4,
January 04, 2022
Tickers
AAPL
ADBE
AMD
LPTH
Tags
ETFs
Commodities
Market News
From
TalkMarkets
The Canadian Cannabis Report - Monday, Jan. 3
January 03, 2022
Tickers
ACB
CNBS
EMHTF
HEXO
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
The Canadian Cannabis Company Index Report Review For 2021
January 03, 2022
Tickers
CGC
HEXO
OGI
TLRY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Happy New Year - Sunday Edition
January 02, 2022
Tickers
ALKS
ANFGF
AZN
BIIB
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
The Week Ahead In Biotech (Jan. 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
January 02, 2022
Tickers
ANGO
AVTX
AZN
BBIO
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
2020-22: Soaring Costs Of The West's Pandemic Failure
January 02, 2022
Tickers
AZN
JNJ
MRNA
PFE
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Fear & Greed In The Biotech Sector
January 02, 2022
Tickers
XBI
Tags
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: Tasly Pharma Acquires Sutro ADC In $385 Million Deal
January 01, 2022
Tickers
STRO
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
A Pfitting End To 2021
December 31, 2021
Tickers
PFE
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
The Rubber Band Trade For A New Year
December 31, 2021
Tickers
ABC
MCK
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Protalix BioTherapeutics: Management Sounds Confident Despite CRL
December 30, 2021
Tickers
PLX
Tags
Pharma/Biotech
Market News
From
TalkMarkets
Healthcare Stocks Are Winners And Provide Diversification To Your Portfolio
December 30, 2021
Tickers
ABBV
IHI
REGN
RHHBY
Tags
Market News
ETFs
Healthcare
From
TalkMarkets
Market Briefing For Wednesday, Dec. 29
December 29, 2021
Tickers
AAPL
AEHR
AMD
CVX
Tags
Energy
Capital & Industrial Goods
Market News
From
TalkMarkets
Top Stock Picks For Week Of December 27, 2021
December 28, 2021
Tickers
ALIT
NVAX
Tags
Market News
Technology
Stocks / Equities
From
TalkMarkets
Investing In This Alzheimer’s Drug Maker Risky But Could Be Quite Rewarding
December 28, 2021
Tickers
SAVA
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Market Briefing For Tuesday, Dec. 28
December 28, 2021
Tickers
HLTH
LPTH
SRNE
UNG
Tags
Commodities
Nonrenewable Energy
Energy
From
TalkMarkets
5 Stocks To Watch For December 27, 2021
December 27, 2021
Tickers
AEZS
ARES
ESCA
NBSE
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
3 Synthetic Biology Stocks In Focus With Strong Potential
December 26, 2021
Tickers
CDXS
NVS
PGEN
VERV
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus
December 26, 2021
Tickers
ADAG
AVTX
AVXL
BBIO
Tags
Market News
Healthcare
Pharma/Biotech
From
TalkMarkets
Week In Review: BeiGene Out-Licenses TIGIT Inhibitor To Novartis In $2.8 Billion Pact
December 26, 2021
Tickers
BGNE
CYTK
NVS
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Santa Finally Showed Up
December 26, 2021
Tickers
BND
DIA
EEM
GLD
Tags
Gold/Precious Metals
Technology
Pharma/Biotech
From
TalkMarkets
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.